The medical community remains optimistic after a handful of experiments found a way to shrink a persistent and harmful form of brain cancer.
Scientists gathered patients’ immune cells and changed them into “living drugs” that scan and fight glioblastoma. These tests temporarily dwindled the size of tumors, researchers reported on Wednesday.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
